HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Influence of lipopolysaccharide-binding protein on pulmonary inflammation in gram-negative pneumonia.

Abstract
Lipopolysaccharide-binding protein (LBP) is upregulated as part of the acute-phase response. Lipopolysaccharide-binding protein has a known multifunctional role in potentiating the recognition, clearance, and killing of gram-negative bacteria. In a Klebsiella pneumonia model, we previously demonstrated that LBP gene-deficient mice (LBP-/-) mice experience increased mortality when compared with wild-type (Wt) mice (98% vs. 59%). We hypothesize that LBP is essential to bacterial clearance from the lung, and its absence leads to alteration of the pulmonary inflammatory response to pneumonia. Twelve- to 16-week-old female C57Bl/6 Wt mice and age-matched LBP-/- mice were administered 1 × 10(3) colony-forming units of Klebsiella pneumoniae by intratracheal injection. Animals were euthanized at 6, 12, 24, or 36 h after inoculation. Lung tissue and bronchoalveolar lavage samples were obtained. Lung homogenate samples were assayed to determine quantitative bacterial load per whole lung, proinflammatory cytokine concentrations, myeloperoxidase activity, and assessment of pulmonary leukocyte populations. In vitro production of inflammatory mediators were also assayed after LPS stimulation of peritoneal macrophages isolated from Wt, Toll-like receptor 4 (TLR4)-deficient, and LBP-/- mice. The LBP-/- mice demonstrated significantly elevated levels of bacteria in the lung at 24 and 36 h when compared with Wt controls. The average lung levels of proinflammatory cytokines interleukin-1β (IL-1β), IL-6, keratinocyte-derived chemokine, and macrophage-inflammatory protein-2 were greater in the LBP mice and remained elevated longer when compared with those in the Wt mice. Myeloperoxidase activity, an indicator of neutrophil content, was significantly increased at time 36 h in the LBP mice. After in vitro stimulation of peritoneal macrophages with LPS, production of IL-1β, IL-6, IL-10, keratinocyte-derived chemokine, and macrophage-inflammatory protein-1α were suppressed in LBP and TLR4-deficient mice compared with that in Wt. Absence of a functional LBP-/- gene results in diminished clearance of gram-negative bacteria from the pulmonary system. Failure to recognize and clear gram-negative bacteria via the LBP/TLR4 axis results in an initial delayed inflammatory response. This delay in LBP-/- mice is followed by excessive amplification and prolonged elevation of proinflammatory mediators and neutrophil sequestration within the lungs.
AuthorsMichael A Taddonio, Vladislav Dolgachev, Markus Bosmann, Peter A Ward, Grace Su, Stewart C Wang, Mark R Hemmila
JournalShock (Augusta, Ga.) (Shock) Vol. 43 Issue 6 Pg. 612-9 (Jun 2015) ISSN: 1540-0514 [Electronic] United States
PMID25643011 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Acute-Phase Proteins
  • Carrier Proteins
  • Chemokine CXCL2
  • Chemokines
  • Interleukin-1beta
  • Interleukin-6
  • Membrane Glycoproteins
  • Toll-Like Receptor 4
  • lipopolysaccharide-binding protein
  • keratinocyte-derived chemokines
Topics
  • Acute-Phase Proteins (genetics, metabolism)
  • Animals
  • Carrier Proteins (genetics, metabolism)
  • Chemokine CXCL2 (metabolism)
  • Chemokines (metabolism)
  • Female
  • Interleukin-1beta (metabolism)
  • Interleukin-6 (metabolism)
  • Lung (immunology, metabolism)
  • Macrophages, Peritoneal (immunology, metabolism)
  • Membrane Glycoproteins (genetics, metabolism)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Pneumonia, Bacterial (genetics, immunology, metabolism)
  • Toll-Like Receptor 4 (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: